Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$6.52 - $20.32 $931,010 - $2.9 Million
142,793 New
142,793 $2.68 Million
Q2 2021

Aug 13, 2021

SELL
$26.34 - $46.62 $1.68 Million - $2.98 Million
-63,952 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$45.96 - $68.02 $205,533 - $304,185
-4,472 Reduced 6.54%
63,952 $3.24 Million
Q4 2020

Feb 11, 2021

BUY
$13.72 - $51.57 $938,777 - $3.53 Million
68,424 New
68,424 $3.32 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.